Financial Year |
March 31 2023 |
Monetary Funds |
119,653,667.47 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
8,568,920.00 |
Accounts Receivable |
259,610,997.85 |
Advances to Suppliers |
9,060,522.84 |
Other Receivables |
11,437,242.11 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
161,046,661.09 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
4,400,508.17 |
Total Current Assets |
614,607,463.84 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
87,809,904.39 |
Long-term Equity Investment |
-- |
Investment Properties |
6,072,913.73 |
Fixed Assetes |
66,929,731.16 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
16,953,399.65 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
8,170,661.61 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
187,601,266.89 |
Total Assets |
802,208,730.73 |
Short-Term Loans |
121,640,251.20 |
Trading Financial liabilities |
-- |
Notes Payable |
2,034,576.00 |
Accounts Payable |
36,116,248.17 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
14,646,372.73 |
Taxes Payable |
11,873,829.56 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
6,177,971.38 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
505,822.61 |
Other Current Liabilities |
4,678,920.00 |
Sub-Total of Current Liabilities |
266,580,806.21 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
10,561,149.18 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
17,562,621.16 |
Total Liabilities |
284,143,427.37 |
Paid-In Capital(Or Share Stock) |
240,457,847.00 |
Capital Surplus |
36,030,462.71 |
Surplus Reserve |
35,475,153.10 |
LESS:Treasury Stock |
4,457,358.00 |
Undistributed Profits |
202,100,984.32 |
Minority Stockholder's Interest |
8,458,214.23 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
509,607,089.13 |
Owner's Equity(Stockholder's Equity) |
518,065,303.36 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
802,208,730.73 |